OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. Read the indications, side effects, and more. Please see Indication and Important Safety Information.

Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO®.

Whether you're a new or continuing OPDIVO® (nivolumab) patient, find resources that can support you through a cancer diagnosis and during treatment. Access helpful resources and find assistance for …

OPDIVO Qvantig is an immunotherapy treatment that is delivered differently than OPDIVO IV. Both work with the immune system in the same way, but OPDIVO Qvantig doesn’t need to be administered at …

This is a summary of important information that you need to know about OPDIVO and OPDIVO + YERVOY. Your healthcare team can work with you to help answer any questions you may have …

Sign up for OPDIVO with You, a support program that offers helpful information if you are about to start or are currently on OPDIVO® (nivolumab) or an OPDIVO®-based combination.

See how OPDIVO® (nivolumab) + CABOMETYX® (cabozantinib) performed in a clinical trials for adults with previously untreated kidney cancer that has spread (advanced renal cell carcinoma or aRCC).

See how OPDIVO® (nivolumab) performed in a clinical trial as a treatment for certain adults with previously treated advanced bladder or urinary tract cancer, or urothelial carcinoma.

Watch videos of real OPDIVO® (nivolumab) patients and caregivers. Learn more about patients' diagnoses and treatment experiences. Please see Indication and Important Safety Information.

OPDIVO® (nivolumab) is a treatment option for certain adults with previously treated classical Hodgkin lymphoma (cHL) whose cancer has come back or spread. Please see Indication and Important …